Author

Karim Aljakouch

German Cancer Research CenterORCID 0000-0002-8330-512XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Research Focus:differential expression· 3 Organism:human· 3 Assay:proteomics· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Assay:ChIP-seq· 2 Approach:deep learning· 2

Frequent Co-Authors

Florian H. GeyeriD· 3 shared Jeroen KrijgsveldiD· 3 shared Thomas G. P. GrünewaldiD· 3 shared Alina Ritter· 2 shared Clémence HenoniD· 2 shared Florencia Cidre‐AranaziD· 2 shared Jing LiiD· 2 shared Olivier DelattreiD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Florian H. GeyerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 17, 2026

Oncogenic fusions induce an extensive cancer-restricted cryptic proteome in Ewing sarcoma

Luuk A. Broeils, Jill Pilet, Maria K. Koshkina…·Sebastiaan van Heesch

The paper shows EWSR1::FLI1 fusion drives the production of cancer-specific neoproteins in Ewing sarcoma, revealing a reversible dark proteome with therapeutic potential.

DOI 10.64898/2026.09.16.751792

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 5, 2025

Exploration of oncogenic cooperation between germline variation and somatic mutation in prostate cancer progression

Zuzanna Kolodynska, Kimberley M. Hanssen, Florian H. Geyer…·Thomas G. P. Grünewald

This study identifies PTPRK as a gene modulated by TMPRSS2::ERG fusion and a regulatory SNP, showing its role in prostate cancer progression and potential as a biomarker.

DOI 10.1101/2025.08.05.668679

humanbulk RNA-seq

𝕏 PostBluesky

Cancer Biology癌症：英文版Peer-reviewedMar 15, 2025

Super-enhancer-driven CACNA2D2 is an EWSR1::WT1 signature gene encoding a diagnostic marker for desmoplastic small round cell tumor (DSRCT)

Florian H. Geyer, Alina Ritter, Seneca S. Kinn-Gurzo…·Florencia Cidre‐Aranaz

The paper identifies CACNA2D2 as a super-enhancer-driven target of EWSR1::WT1 and demonstrates its utility as a diagnostic biomarker for DSRCT.

12 citationstop 4%

humanscRNA-seq

𝕏 PostBluesky